Perrigo Company plc (NYSE:PRGO) Shares Sold by Copeland Capital Management LLC

Copeland Capital Management LLC reduced its position in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 3.7% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 2,389,764 shares of the company's stock after selling 92,780 shares during the quarter. Copeland Capital Management LLC owned about 1.75% of Perrigo worth $61,441,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Versant Capital Management Inc purchased a new position in shares of Perrigo during the 4th quarter worth about $45,000. GAMMA Investing LLC raised its holdings in shares of Perrigo by 93.7% in the fourth quarter. GAMMA Investing LLC now owns 1,920 shares of the company's stock worth $49,000 after buying an additional 929 shares during the period. Central Pacific Bank Trust Division boosted its holdings in Perrigo by 33.3% during the 4th quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company's stock valued at $51,000 after acquiring an additional 500 shares during the period. Venturi Wealth Management LLC bought a new position in Perrigo in the 3rd quarter valued at $56,000. Finally, KBC Group NV lifted its position in shares of Perrigo by 25.1% during the third quarter. KBC Group NV now owns 4,517 shares of the company's stock worth $118,000 after purchasing an additional 905 shares during the last quarter. Institutional investors own 95.91% of the company's stock.

Perrigo Stock Down 0.2 %

Shares of Perrigo stock traded down $0.05 during trading on Wednesday, reaching $25.05. The company's stock had a trading volume of 397,625 shares, compared to its average volume of 1,334,819. Perrigo Company plc has a 1-year low of $23.14 and a 1-year high of $33.46. The company has a 50-day simple moving average of $25.88 and a two-hundred day simple moving average of $26.55. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94. The company has a market cap of $3.42 billion, a price-to-earnings ratio of -21.41 and a beta of 0.54.

Perrigo (NYSE:PRGO - Get Free Report) last released its earnings results on Wednesday, November 6th. The company reported $0.81 EPS for the quarter, hitting analysts' consensus estimates of $0.81. The firm had revenue of $1.09 billion during the quarter, compared to the consensus estimate of $1.12 billion. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The company's revenue was down 3.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.64 earnings per share. As a group, equities analysts forecast that Perrigo Company plc will post 2.56 earnings per share for the current year.

Insider Activity at Perrigo

In related news, Director Jeffrey B. Kindler sold 17,598 shares of the stock in a transaction on Monday, December 9th. The shares were sold at an average price of $28.27, for a total transaction of $497,495.46. Following the sale, the director now directly owns 5,409 shares of the company's stock, valued at approximately $152,912.43. This represents a 76.49 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 0.40% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on PRGO. StockNews.com lowered shares of Perrigo from a "buy" rating to a "hold" rating in a research report on Saturday, January 11th. Argus lowered Perrigo from a "buy" rating to a "hold" rating in a report on Tuesday, January 14th. Finally, Piper Sandler downgraded Perrigo from an "overweight" rating to a "neutral" rating and cut their price target for the company from $34.00 to $27.00 in a report on Monday, January 6th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $35.00.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.